Stefan Oelrich
Corporate Officer/Principal bei BAYER AG
Profil
Stefan Oelrich is currently a Director at Vividion Therapeutics, Inc. and a President-Pharmaceuticals Division at Bayer AG.
He is also a Member-Management Board at American Chamber of Commerce in Germany eV, an Advisor at Longwood Fund Management LLC, and a Member-Supervisory Board at Berlin Institute of Health.
Previously, he worked as an Executive VP-Diabetes & Cardiovascular at Sanofi from 2011 to 2018.
Aktive Positionen von Stefan Oelrich
| Unternehmen | Position | Beginn |
|---|---|---|
| BAYER AG | Corporate Officer/Principal | 01.11.2018 |
| Berlin Institute of Health | Direktor/Vorstandsmitglied | 01.01.2016 |
American Chamber of Commerce in Germany eV
 American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany. | Direktor/Vorstandsmitglied | - |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Berater | - |
Ehemalige bekannte Positionen von Stefan Oelrich
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 30.09.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANOFI | Health Technology |
| BAYER AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Berlin Institute of Health | |
American Chamber of Commerce in Germany eV
American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany. | Commercial Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Finance |
